Spruce Biosciences SPRB
NASDAQ SPRB
$42.22 +0.99 (+2.41%)
As of: Oct 21, 2026 · 2:20 PM EDT

Spruce Biosciences (SPRB) Receivables - Net (2023)

Updated

Spruce Biosciences (SPRB) reported Receivables - Net of $15 million for Q1 2023.

Analysis

Spruce Biosciences (SPRB) Receivables - Net (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Spruce Biosciences 102.65 Mn -107.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.00 Mn
API Access

Spruce Biosciences Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=SPRB&period=max&api_key=YOUR_API_KEY